NPPA issued a notification regarding the fixation of the retail price of Dapagliflozin Propanediol USP eq to Dapagliflozin 10mg + Glimepiride IP 2 mg + Metformin Hydrochloride IP 500mg

Jun 27, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on June 26, 2024, issued a notification regarding the fixation of the retail price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2 mg + Metformin Hydrochloride IP 500mg.

The following has been stated: -

•Each film-coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2 mg + Metformin Hydrochloride IP 500mg (as Extended release) for M/s Mascot Healthcare Series Pvt Ltd. (Manufacturer) & M/ Aprica HealthCare Ltd (Marketer) and the retail price is 15. 36 (Rs.)

The detailed notification is given in the document below.

[Notification No. 19(4070)/2024/DP/NPPA/DIV.III/8375/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT